Newsroom
Your source for Evernorth news.
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Estimated to save individual Accredo patients around $4,000 per year
Biosimilar price will be more than 80% lower than Stelara list price
Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (50)
Press Release
New Express Scripts app feature gives customers easy, secure access to digital COVID vaccination record
September 20, 2021
Press Release
Express Scripts Awarded 7-Year TRICARE Pharmacy Program Contract
August 06, 2021
New contract gives Express Scripts the honor of serving TRICARE beneficiaries through 2029
Press Release
Evernorth to Expand Weight Management Program to include Wegovy
June 10, 2021
- Patients enrolled in the Weight Management Care Value program from Express Scripts also benefit from robust personalized coaching, digital tracking tools and peer support
- MDLIVE physicians will be available to meet with WMCV participants virtually and can prescribe appropriate weight loss medications, including Wegovy, for eligible patients.
- Industry-leading value-based care model provides employers and health plans with greater affordability and predictability
Press Release
Evernorth Completes Acquisition of MDLIVE to Expand Access to Virtual Care
April 19, 2021
Acquisition expands Evernorth’s capabilities to lower the cost of care – while increasing access to health care providers – through virtual visits
Press Release
As Demand for Virtual Health Care Surges, Evernorth Announces Acquisition of Long-Term Partner, MDLIVE
February 26, 2021
Transaction creates a convenient and connected care experience for consumers, rapidly expands Evernorth’s portfolio and delivers accelerated growth.
Press Release
Despite Stressors of Pandemic, 60 Percent of Women Say Their Plans to Have Children Have Not Changed, New Evernorth Report Finds
February 24, 2021
Three out of four women that stopped fertility treatments during the pandemic have either restarted or plan to within a year. Nearly 20 percent of older millennials and younger GenX women are accelerating plans to have children, and 13 percent of respondents 25-45 are planning to have more children than previously planned.